• Clincierge to Host Patient Experience Panel at BIO International 2022

    2 monthes ago - By San Diego Biotechnology

    PHILADELPHIA, June 2, 2022 /PRNewswire/ - Clincierge today announced CEO Scott Gray will moderate Participant Sensitivity: Amplifying the Voice of the Patient in Clinical Trials at the upcoming 2022 BIO International Convention on June 13-16,...
    Read more ...

     

  • EPIC SCIENCES RAISES $43M IN FIRST CLOSE OF SERIES F FINANCING TO ADVANCE COMPREHENSIVE PROFILING FOR METASTATIC CANCER PATIENTS

    2 monthes ago - By San Diego Biotechnology

    Funding will accelerate commercial launch of DefineMBC™ and expand Epic Sciences' liquid biopsy solutions for key global oncology trials SAN DIEGO, June 2, 2022 /PRNewswire/ - Epic Sciences, Inc. , a privately...
    Read more ...

     

  • Viracta Therapeutics Provides an Update on the Phase 1b/2 Trial of Nana-val in Patients with Advanced Epstein-Barr Virus-Positive Solid Tumors and Announces Upcoming Poster Presentation at the ASCO Annual Meeting

    2 monthes ago - By San Diego Biotechnology

    Trial has advanced to the second dose escalation cohort with no dose-limiting toxicities observed to-date SAN DIEGO, June 2, 2022 /PRNewswire/ - Viracta Therapeutics, Inc. , a precision oncology company targeting virus-associated malignancies, today...
    Read more ...

     

  • Caris Life Sciences, Prostate Cancer Clinical Trial Consortium and Sorrento Therapeutics Announce Collaboration to Advance Precision Medicine Development Using Comprehensive Genomic Profiling

    2 monthes ago - By San Diego Biotechnology

    Collaboration will comprehensively profile DNA, RNA and proteins on patient samples from the Phase 2 Maverick trial to understand mechanisms of disease response and resistance IRVING, Texas and SAN DIEGO, June 2, 2022 /PRNewswire/ -...
    Read more ...